Answers are grounded in this paper and cite their sources.
Cross-sectional study assesses the Mentzer index's diagnostic accuracy for beta thalassemia trait, suggesting a viable alternative to Hb electrophoresis.
Background: Beta thalassemia trait (BTT) is a common genetic disorder and a significant cause of microcytic anemia. Hemoglobin (Hb) electrophoresis is the gold standard for diagnosis, but its cost and availability are major concerns in resource-limited settings. The Mentzer index, a simple calculation using CBC parameters, has been proposed as a cost-effective alternative. Objective: To determine the diagnostic accuracy of the Mentzer index in identifying beta thalassemia trait using Hb electrophoresis as the gold standard. Methods: This cross-sectional validation study was conducted at the Department of Pediatrics, KRL Hospital, Islamabad over 6 months from September 2024 to February 2025. Children aged 4–16 years with Hb < 10.5 g/dL and MCV < 80 fL were enrolled. Mentzer index was calculated (MCV/RBC count), and Hb electrophoresis was performed. Diagnostic accuracy of Mentzer index < 13 was assessed against HbA2 > 3.5% on electrophoresis. Results: Among 242 children, the Mentzer index <13 showed a sensitivity of 92.5%, specificity of 87.2%, PPV of 90.2%, NPV of 89.2%, and overall accuracy of 90.2% in detecting beta thalassemia trait. Conclusion: The Mentzer index shows promising diagnostic potential in screening for beta thalassemia trait and may be used as a preliminary tool in settings where Hb electrophoresis is inaccessible or unaffordable.
No takes yet. Share an insight, caveat, or question.
Zehra et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: